And, earlier this year, the government asked drug makers to extend that warning to patients age eighteen to twenty-four during initial treatment.

• 在今年早些时候，政府要求药物制造商在该药品上增加警告字样，在初期治疗时就告知年龄在十八至二十四岁间的病人。